Facebook
Prescribing Information Important Safety Information To Healthcare Professional Site
facebook

The Established Safety of AFSTYLA

AFSTYLA safety was evaluated in 258 previously treated patients (PTPs) and 24 previously untreated patients (PUPs)

ZERO INHIBITORS

14 of 258 participants reported experiencing a side effect

One person withdrew due to an allergic reaction (hypersensitivity).

In clinical trials, the most common side effects reported in >0.5% of subjects were

  • Factor VIII inhibition in previously untreated patients
  • Dizziness
  • Allergic reaction (hypersensitivity)
    • One person withdrew from the study due to hypersensitivity
You are now leaving the current website.

Do you want to continue?

No Yes